Skip to content
Home/Companies/Pharma/Labomar
LA

Labomar

Pharma·Italy·Active·3yr hold

Labomar is a pharma company, headquartered in Italy.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Labomar?

Labomar is currently owned by Charterhouse Capital Partners through Charterhouse Capital Partners XI (2023 vintage), since 2023.

Hand-verified · updated 2026-07-08

Charterhouse Capital Partners
Investor
Charterhouse Capital Partners
Charterhouse Capital Partners XI · 2023 · Buyout

Key facts

HQItaly
SectorPharma
StatusActive

More from Charterhouse Capital Partners XI

Other portfolio companies in the same fund.

ESTYA
Active
Business ServicesFrance· 2025
Winback
Active
MedTechFrance· 2025
Metrodora
Active
EducationSpain· 2024
Skin Tech Pharma Group
Active
HealthcareSpain· 2024
Two Circles
Active
Business ServicesUK· 2024
France Valley
Active
Real EstateFrance· 2023

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings